A 12-month open-label trial of mycophenolate mofetil in multiple sclerosis

被引：0
|
作者：
Gogovska, L [1 ]
Ljapcev, R [1 ]
机构：
[1] Neurol Clin, Skopje, Macedonia
来源：
MULTIPLE SCLEROSIS | 2004年 / 10卷 / 7032期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S263 / S264
页数：2
相关论文
共 50 条
  • [41] Moclobemide treatment in multiple sclerosis patients with comorbid depression: An open-label safety trial
    Barak, Y
    Ur, E
    Achiron, A
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 1999, 11 (02) : 271 - 273
  • [42] Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial
    Laroni, A.
    Brogi, D.
    Morra, V. Brescia
    Guidi, L.
    Pozzilli, C.
    Comi, G.
    Lugaresi, A.
    Turrini, R.
    Raimondi, D.
    Uccelli, A.
    Mancardi, G.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 509 - 510
  • [43] Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial
    Laroni, Alice
    Brogi, Davide
    Morra, Vincenzo Brescia
    Guidi, Leonello
    Pozzilli, Carlo
    Comi, Giancarlo
    Lugaresi, Alessandra
    Turrini, Renato
    Raimondi, Debora
    Uccelli, Antonio
    Mancardi, Giovanni Luigi
    BMC NEUROLOGY, 2014, 14
  • [44] Oral mycophenolate mofetil in the treatment of acquired dermal macular hyperpigmentation: An open-label pilot study
    Bishnoi, Anuradha
    Vinay, Keshavamurthy
    Parsad, Davinder
    Kumar, Sheetanshu
    Chatterjee, Debajyoti
    Saikia, Uma Nahar
    Kumaran, Muthu Sendhil
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2021, 62 (03) : 278 - 285
  • [45] Mycophenolate Mofetil in Multiple Sclerosis: A Retrospective Study
    Michel, Laure
    Ongagna, Jean-Claude
    Laplaud, David Axel
    Fleury, Mary
    Blanc, Frederic
    De Seze, Jerome
    Wiertlewski, Sandrine
    NEUROLOGY, 2009, 72 (11) : A361 - A361
  • [46] Adjunct modafinil improves excessive sleepiness in obstructive sleep apnea: A 12-month open-label extension study
    Williams, A
    THORAX, 2003, 58 : 7 - 7
  • [47] Clinical development of mycophenolate mofetil in multiple sclerosis
    Davies, S. L.
    Moral, M. A.
    DRUG NEWS & PERSPECTIVES, 2006, 19 (10) : 632 - 633
  • [48] A 12-Month Open-Label Extension Study of the Safety and Tolerability of Lisdexamfetamine Dimesylate for Major Depressive Disorder in Adults
    Richards, Cynthia
    Iosifescu, Dan V.
    Mago, Rajnish
    Sarkis, Elias
    Geibel, Brooke
    Dauphin, Matthew
    McIntyre, Roger S.
    Weisler, Richard
    Brawman-Mintzer, Olga
    Gu, Joan
    Madhoo, Manisha
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2018, 38 (04) : 336 - 343
  • [49] Efficacy and tolerability of quetiapine in the treatment of bipolar disorder: preliminary evidence from a 12-month open-label study
    Altamura, AC
    Salvadori, D
    Madaro, D
    Santini, A
    Mundo, E
    JOURNAL OF AFFECTIVE DISORDERS, 2003, 76 (1-3) : 267 - 271
  • [50] Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial
    Alice Laroni
    Davide Brogi
    Vincenzo Brescia Morra
    Leonello Guidi
    Carlo Pozzilli
    Giancarlo Comi
    Alessandra Lugaresi
    Renato Turrini
    Debora Raimondi
    Antonio Uccelli
    Giovanni Luigi Mancardi
    BMC Neurology, 14
12345